Leerink Partners Raises Price Target on Diplomat Pharmacy (DPLO) to $36 Following 1Q Beat

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. AAPL
2. BRZE
3. TTAN
4. CHYM
5. USO
6. COO
7. QCOM
8. IRT
9. AEO
10. MSI

Go back to Leerink Partners Raises Price Target on Diplomat Pharmacy (DPLO) to $36 Following 1Q Beat

After-Hours Stock Movers 05/09: (STMP) (OPK) (HALO) Higher; (NLNK) (GPS) (BLOX) (RAX) Lower (more...)

May 9, 2016 6:25 PM EDT

NewLink Genetics Corporation (NASDAQ: NLNK) 34.5% LOWER; announced today results of its Phase 3 clinical trial for algenpantucel-L for patients with resected pancreatic cancer. The IMPRESS Phase 3 study of algenpantucel-L for patients with resected pancreatic cancer did not achieve its primary endpoint. Overall survival from time of randomization was 29.3 months for both groups combined. There was no statistically significant difference between the two groups. The median survival was 30.4 months and 27.3 months for the control and study groups, respectively. There was also no statistical difference for long-term survival. Three year survival was... More

Diplomat Pharmacy (DPLO) Tops Q1 EPS by 5c

May 9, 2016 4:15 PM EDT

Diplomat Pharmacy (NYSE: DPLO) reported Q1 EPS of $0.23, $0.05 better than the analyst estimate of $0.18. Revenue for the quarter came in at $995.9 million versus the consensus estimate of $982.87 million.

For earnings history and earnings-related data on Diplomat Pharmacy (DPLO) click here.

... More

Trading Radar for 5/9: Tyson Foods (TSN), Stratasys (SSYS), Wayfair (W), MBIA (MBI) Report

May 6, 2016 2:45 PM EDT

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:
Earnings:

AES Corp (Nasdaq: AES) - consensus EPS $0.20
Alaska Communications Systems (Nasdaq: ALSK) - consensus EPS $0.00
Altisource Residential (Nasdaq: RESI) - consensus loss $0.06
Apricus Biosciences (Nasdaq: APRI) - consensus loss $0.09
Armstrong World (Nasdaq: AWI) - consensus EPS $0.41
BIND Therapeutics (Nasdaq: BIND) - consensus loss... More